Entradas por LIN-BCN

25335786

Short-Term Blood Pressure Variability Relates to the Presence of Subclinical Brain Small Vessel Disease in Primary Hypertension. Filomena J, Riba-Llena I, Vinyoles E, Tovar JL, Mundet X, Castañé X, Vilar A, López-Rueda A, Jiménez-Baladó J, Cartanyà A, Montaner J, Delgado P. Hypertension. 2015 Jun 22. pii: HYPERTENSIONAHA.115.05440. [Epub ahead of print]

25335783

Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9. Hernandez-Guillamon M, Mawhirt S, Blais S, Montaner J, Neubert TA, Rostagno A, Ghiso J. J Biol Chem. 2015 Jun 12;290(24):15078-91.

International collaboration between VHIR and UAB for Cerebral Infarction treatment

http://www.uab.cat/web/sala-de-premsa/detall-de-noticia/col-laboracio-internacional-de-la-uab-i-el-vhir-per-al-tractament-de-l-8217-infart-cerebral-1345667174054.html?noticiaid=1345686475372   The Neurovascular Diseases group of Vall d’hebron Institute of Research (VHIR) and the Institut de Neurociències UAB have signed a collaborative agreement with the Japanese company R-Tech Ueno, to develop a novel VAP-1 inhibitor for treatment of cerebral infarction. RTU-009 is a novel VAP-1 inhibitor, having an anti-inflammatory and neuroprotective effect. It is […]

25335785

High daytime and nighttime ambulatory pulse pressure predict poor cognitive function and mild cognitive impairment in hypertensive individuals. Riba-Llena I, Nafría C, Filomena J, Tovar JL, Vinyoles E, Mundet X, Jarca CI, Vilar-Bergua A, Montaner J, Delgado P. J Cereb Blood Flow Metab. 2015 May 13. doi: 10.1038/jcbfm.2015.90. [Epub ahead of print]

25335782

Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunami. Martínez-Lizana E, Carmona-Iragui M, Alcolea D, Gómez-Choco M, Vilaplana E, Sánchez-Saudinós MB, Clarimón J, Hernández-Guillamon M, Munuera J, Gelpi E, Gómez-Anson B, de Juan-Delago M, Delgado-Mederos R, Montaner J, Ois A, Amaro S, Blesa R, Martí-Fàbregas J, Lleó A, Fortea J. J Cereb […]

25335781

B-type natriuretic peptides help in cardioembolic stroke diagnosis: pooled data meta-analysis. Llombart V, Antolin-Fontes A, Bustamante A, Giralt D, Rost NS, Furie K, Shibazaki K, Biteker M, Castillo J, Rodríguez-Yáñez M, Fonseca AC, Watanabe T, Purroy F, Zhixin W, Etgen T, Hosomi N, Jafarian Kerman SR, Sharma JC, Knauer C, Santamarina E, Giannakoulas G, García-Berrocoso […]

25335784

Blood and CSF biomarkers in brain subcortical ischemic vascular disease: involved pathways and clinical applicability. Vilar-Bergua A, Riba-Llena I, Nafría C, Bustamante A, Llombart V, Delgado P, Montaner J. J Cereb Blood Flow Metab. 2015 Apr 22. doi: 10.1038/jcbfm.2015.68.

25335791

Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease. Rannikmäe K, Davies G, Thomson PA, Bevan S, Devan WJ, Falcone GJ, Traylor M, Anderson CD, Battey TW, Radmanesh F, Deka R, Woo JG, Martin LJ, Jimenez-Conde J, Selim M, Brown DL, Silliman SL, Kidwell CS, Montaner J, Langefeld CD, Slowik A, Hansen […]

25335780

Endothelial progenitor cells and revascularization following stroke. Ma F, Morancho A, Montaner J, Rosell A. Brain Res. 2015 Feb 26. pii: S0006-8993(15)00094-3. doi: 10.1016/j.brainres.2015.02.010.

25335779

NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke. Merino-Zamorano C, Hernández-Guillamon M, Jullienne A, Le Béhot A, Bardou I, Parés M, Fernández-Cadenas I, Giralt D, Carrera C, Ribó M, Vivien D, Ali C, Rosell A, Montaner J. Stroke. 2015 Feb;46(2):477-84. doi: 10.1161/STROKEAHA.114.006826. Epub 2014 Dec 11.